DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Wallentin L, Hijazi Z, Andersson U. , et al; ARISTOTLE Investigators.
Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Circulation 2014;
130 (21) 1847-1858
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.